Cover

Guides Introduction to combination therapy

Lipodystrophy and metabolic changes

Lipodystrophy refers to changes in fat cells and the distribution of body fat. It also refers to changes in blood fat and blood sugar levels (metabolic changes).

  • It is not known why some people get these changes.
  • They are less common with newer meds.
  • The greater awareness of lipodystrophy means that you will be monitored carefully.
  • The changes usually, but not always, develop slowly over many months.

If you have any worries, make sure your doctor takes them seriously and does something about it.

Fat loss (from arms, legs, face and buttocks) is now unlikely with new drugs. This was linked to d4T and AZT which are no longer used in the UK.

Fat accumulation to the stomach or breasts and/or across the shoulders or neck has been linked to combinations that include protease inhibitors and NNRTIs.

Mild symptoms may reverse if you switch to different HIV meds. Exercise and dietary changes can also help.

Changes in fat (cholesterol and triglyceride) and sugar (glucose) levels are linked to many drugs and will be monitored by routine blood and/or urine tests.

Diet, exercise, changing treatment or using lipid lowering drugs can all help.


April 2012

Decisions relating to your treatment should always be taken in consultation with your doctor. Information in this guide is intended to support those discussions.

Authors and referencesTranslationsAbout our guidesGuides index

This guide's available in UK clinics (can't find it?)

We comply with the HONcode standard for trustworthy health information: verify here



HIV i-Base
Treatment phoneline: 0808 800 6013 • Mon-Wed 12-4pm • Office: 020 7407 8488 • Email: admin@i-base.org.uk • Website: www.i-base.info